V Bryan Lawlis's Net Worth
$9.41 Million
Who is V Bryan Lawlis?
V Bryan Lawlis has an estimated net worth of $9.41 Million. This is based on reported shares across multiple companies, which include BIOMARIN PHARMACEUTICAL INC, GERON CORP, SUTRO BIOPHARMA INC, Coherus BioSciences, Inc., Aeglea BioTherapeutics, Inc., KALOBIOS PHARMACEUTICALS INC, and ARADIGM CORP.
SEC CIK
V Bryan Lawlis's CIK is 0001247681
Past Insider Trading and Trends
2015 was V Bryan Lawlis's most active year for acquiring shares with 11 total transactions. V Bryan Lawlis's most active month to acquire stocks was the month of April. 2018 was V Bryan Lawlis's most active year for disposing of shares, totalling 10 transactions. V Bryan Lawlis's most active month to dispose stocks was the month of May. 2015 saw V Bryan Lawlis paying a total of $934,505.25 for 156,900 shares, this is the most they've acquired in one year. In 2023 V Bryan Lawlis cashed out on 87,000 shares for a total of $930,265.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $90.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.47% | 4.19K |
—
|
—
| 33.14K |
May 23
| |||
Form 4
|
—
|
0
|
$82.45 | -$248,880.00 | 28.95K |
Apr 3
| |||
Form 4
| +20.78% | 4.98K |
—
|
—
| 28.95K |
May 24
| |||
Form 4
|
—
|
0
|
$60.56 | -$196,350.00 | 23.97K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$62.54 | -$213,137.50 | 23.97K |
Scheduled
|
Jan 14
| ||
Form 4
| +27.16% | 5.12K |
—
|
—
| 23.97K |
May 25
| |||
Form 4
|
—
|
0
|
$51.70 | -$378,075.00 | 18.85K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$56.95 | -$456,900.00 | 18.85K |
Scheduled
|
Feb 16
| ||
Form 4
| -19.03% | -4.43K |
$107.46 | -$476,047.80 | 18.85K |
Scheduled
|
Jun 5
| ||
Form 4
| +22.66% | 4.3K |
—
|
—
| 23.28K |
May 27
| |||
Form 4
| -19.54% | -4.61K |
$48.76 | -$554,807.20 | 18.98K |
Scheduled
|
Mar 16 - Mar 17
| ||
Form 4
|
—
|
0
|
$52.44 | -$231,937.50 | 23.59K |
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
$47.99 | -$198,600.00 | 23.59K |
Scheduled
|
Sep 17
| ||
Form 4
|
—
|
0
|
$51.30 | -$223,387.50 | 23.59K |
Scheduled
|
Jun 17
| ||
Form 4
| +23.12% | 4.43K |
—
|
—
| 23.59K |
Jun 4
| |||
Form 4
|
—
|
0
|
$52.08 | -$162,045.50 | 19.16K |
Scheduled
|
Mar 27
| ||
Form 4
|
—
|
0
|
$48.46 | -$146,501.00 | 19.16K |
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
$56.16 | -$179,611.00 | 19.16K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
$53.96 | -$170,129.50 | 19.16K |
Scheduled
|
Jun 27
| ||
Form 4
| +28.94% | 4.3K |
—
|
—
| 19.16K |
Jun 5
| |||
Form 4
|
—
|
0
|
$61.80 | -$174,037.50 | 14.86K |
Scheduled
|
Apr 17
| ||
Form 4
|
—
|
0
|
$63.72 | -$188,437.50 | 14.86K |
Scheduled
|
Jan 2
| ||
Form 4/A
|
—
|
0
|
—
|
—
| 13.36K |
Jun 6
| |||
Form 4
|
—
|
0
|
$64.93 | -$197,512.50 | 15.91K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$64.30 | -$192,787.50 | 15.91K |
Scheduled
|
Jun 16
| ||
Form 4
| +14.79% | 2.05K |
—
|
—
| 15.91K |
Jun 6
| |||
Form 4
|
—
|
0
|
$56.17 | -$582,525.00 | 13.86K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$56.17 | -$582,525.00 | 13.86K |
Scheduled
|
Nov 9
| ||
Form 4
|
—
|
0
|
$56.36 | -$85,863.80 | 13.86K |
Scheduled
|
Jul 27
| ||
Form 4
|
—
|
0
|
$56.17 | -$497,152.00 | 13.86K |
Scheduled
|
Jul 22
| ||
Form 4
| -3.82% | -550.00 |
$82.77 | -$45,523.50 | 13.86K |
Scheduled
|
Jun 20
| ||
Form 4
| +11.71% | 1.51K |
—
|
—
| 14.41K |
Jun 6
| |||
Form 4
| +108.14% | 13.95K |
$83.28 | $825,037.29 | 11.85K |
Scheduled
|
Nov 16
| ||
Form 4
| +9.32% | 1.1K |
—
|
—
| 12.9K |
Jun 10
| |||
Form 4
| +21.65% | 2.1K |
—
|
—
| 11.8K |
Jun 4
| |||
Form 4
| -14.91% | -1.70K |
$56.87 | -$96,672.03 | 9.7K |
Scheduled
|
May 16
| ||
Form 4
| -20.28% | -2.90K |
$69.76 | -$202,300.81 | 11.4K |
Dec 9
| |||
Form 4
| +31.19% | 3.4K |
—
|
—
| 14.3K |
May 15
| |||
Form 4/A
| -18.66% | -2.50K |
$26.45 | -$250,673.26 | 10.9K |
May 15
| |||
Form 4
| -7.00% | -2.50K |
$26.45 | -$250,673.26 | 33.2K |
May 15
| |||
Form 4
| +34.00% | 3.4K |
—
|
—
| 13.4K |
May 8
| |||
Form 4
| +33.33% | 2.5K |
—
|
—
| 10K |
May 12
| |||
Form 4
| +50.00% | 2.5K |
—
|
—
| 7.5K |
May 12
| |||
Form 4
| +100.00% | 2.5K |
—
|
—
| 5K |
May 22
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
| No matching records found | |||||||||
GERON CORP (GERN) Snapshot price: $1.905
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
$2.05 | -$66,500.00 |
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.695
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coherus BioSciences, Inc. (CHRS) Snapshot price: $2.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||